OSTEAL THERAPEUTICS, INC.
- Country
- ๐บ๐ธUnited States
- Ownership
- Holding
- Established
- 2013-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.ostealtx.com
Expanded Access to Cyclic Irrigation in Patients Undergoing Exchange Arthroplasty
- Conditions
- Prosthetic-joint Infection
- First Posted Date
- 2024-04-25
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- Osteal Therapeutics, Inc.
- Registration Number
- NCT06383611
- Locations
- ๐บ๐ธ
Banner - University Medical Center Phoenix, Phoenix, Arizona, United States
๐บ๐ธUniversity of Florida Health, Gainesville, Florida, United States
๐บ๐ธMayo Clinic Jacksonville, Jacksonville, Florida, United States
A Second Trial of the Abbreviated Protocol Two-Stage Exchange
- Conditions
- Prosthetic-joint Infection
- Interventions
- Combination Product: VT-X7 Treatment SystemProcedure: Two-stage exchange arthroplastyDrug: SOC AntibioticsDrug: Experimental Antibiotics
- First Posted Date
- 2022-11-07
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- Osteal Therapeutics, Inc.
- Target Recruit Count
- 76
- Registration Number
- NCT05607030
- Locations
- ๐บ๐ธ
University of Missouri, Columbia, Missouri, United States
๐บ๐ธThe Ohio State University Medical Center, Columbus, Ohio, United States
๐บ๐ธHarbor UCLA Medical Center, Los Angeles, California, United States
Abbreviated Protocol for Two-Stage Exchange
- Conditions
- Prosthetic Joint Infection
- Interventions
- Combination Product: VT-X7 Treatment System with Tobramycin SulfateDrug: Standard of CareProcedure: Two-stage exchange arthroplastyCombination Product: VT-X7 Treatment System with Vancomycin Hydrochloride
- First Posted Date
- 2020-12-10
- Last Posted Date
- 2024-04-02
- Lead Sponsor
- Osteal Therapeutics, Inc.
- Target Recruit Count
- 76
- Registration Number
- NCT04662632
- Locations
- ๐บ๐ธ
University of Arizona, Phoenix, Phoenix, Arizona, United States
๐บ๐ธVA Medical Center, Washington, District of Columbia, United States
๐บ๐ธHarbor-UCLA Medical Center, Torrance, California, United States
Safety and Efficacy in Patients Treated for Hip or Knee PJI With Vancomycin and Tobramycin Joint Irrigation
- Conditions
- Prosthetic Joint Infection
- Interventions
- Combination Product: vancomycin hydrochloride and tobramycin sulfate
- First Posted Date
- 2018-10-26
- Last Posted Date
- 2022-01-11
- Lead Sponsor
- Osteal Therapeutics, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT03721328
- Locations
- ๐บ๐ธ
Covenant Hospital, Saginaw, Michigan, United States
๐บ๐ธSSM Health Bone and Joint Hospital at St. Anthony, Oklahoma City, Oklahoma, United States
๐บ๐ธOrtho Carolina Research Institute, Charlotte, North Carolina, United States